Buy or sell bit.bio stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

bit.bio Stock

bit.bio represents the two fields coding and biology that determine the identity of every human cell.

About bit.bio Stock

bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.

Funding History

November 2017$350K
June 2020$41.5M

Management

Founder

Mark Kotter

CFO & COO

Florian Schuster

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from bit.bio or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo